NASDAQ:BLRX
BioLineRx Ltd. Stock News
$0.612
+0.0363 (+6.31%)
At Close: Apr 26, 2024
Jazz's Aggressive Lung Cancer Drug Zepzelca Gets FDA Approval
02:15pm, Tuesday, 16'th Jun 2020
FDA's accelerated approval to Jazz's (JAZZ) Zepzelca as a monotherapy for metastatic small cell lung cancer patients set to boost the company's oncology portfolio.
Is Bioline RX Ltd (BLRX) Going to Burn These Hedge Funds?
11:23pm, Thursday, 04'th Jun 2020
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investmen
BioLineRx Announces $4.39 Million Registered Direct Offering
12:19pm, Monday, 01'st Jun 2020BioLineRx Announces $4.39 Million Registered Direct Offering
12:00pm, Monday, 01'st Jun 2020
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical company focused on oncology, today announced that it has entered into definitive agreements with several healthcare-
Top Ranked Momentum Stocks to Buy for May 29th
03:46pm, Friday, 29'th May 2020
Top Ranked Momentum Stocks to Buy for May 29th
3 “Strong Buy” Biotech Stocks Under $5 With Explosive Upside Potential
01:49pm, Wednesday, 27'th May 2020
Which stocks are leading the pack out on Wall Street? Biotechs. Understandably, investors have taken a more cautious approach when navigating the confused financial environment, but focus is locking i
BioLineRx Announces Publication of Data from Ongoing COMBAT/KEYNOTE-202 Clinical Trial in Nature Medicine
11:00am, Wednesday, 27'th May 2020
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical Company focused on oncology, today announced that a paper, entitled 'BL-8040, a CXCR4 Antagonist, in Combination with Pem
Mid-Afternoon Market Update: Crude Oil Up 2%; argenx Shares Spike Higher
06:32pm, Tuesday, 26'th May 2020Mid-Day Market Update: Dow Jumps Over 600 Points; BioLineRx Shares Plunge
04:21pm, Tuesday, 26'th May 2020Mid-Morning Market Update: Markets Open Higher; AutoZone Beats Q3 Expectations
02:16pm, Tuesday, 26'th May 2020BioLineRx Announces $9.0 Million Registered Direct Offering
12:40pm, Tuesday, 26'th May 2020
BioLineRx Ltd. (Nasdaq: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical company focused on oncology, today announced that it has entered into definitive agreements with several healthcare-
